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ABSTRACT
The generalized propensity score (GPS) is an extension of the propensity score for use with quantita-
tive or continuous exposures (e.g., dose of medication or years of education). Current GPS methods
allow estimation of the dose-response relationship between a single continuous exposure and an out-
come. However, in many real-world settings, there are multiple exposures occurring simultaneously
that could be causally related to the outcome. We propose a multivariate GPS method (mvGPS) that
allows estimation of a dose-response surface that relates the joint distribution of multiple continu-
ous exposure variables to an outcome. The method involves generating weights under a multivariate
normality assumption on the exposure variables. Focusing on scenarios with two exposure variables,
we show via simulation that the mvGPS method can achieve balance across sets of confounders that
may differ for different exposure variables and reduces bias of the treatment effect estimates under a
variety of data generating scenarios. We apply the mvGPS method to an analysis of the joint effect
of two types of intervention strategies to reduce childhood obesity rates.
Keywords childhood obesity · dose response · observational studies · combination therapy · estimable regions ·
convex hull
1 Introduction
Analyzing data from observational studies and non-randomized experiments to estimate causal effects is challenging
due to potential confounding between the exposure and outcome. Techniques such as propensity score methods can
help to remove sources of potential confounding and return valid estimates of the treatment effect [39]. Propensity
score methods were first developed for binary treatments, and then extended to categorical, or multiple, treatments,
which introduced the term “generalized propensity score” (GPS) [21]. In the context of a categorical treatment vari-
able, the GPS corresponds to the conditional probability of receiving a particular treatment given a set of confounders.
Following the extension to categorical treatments, the GPS was adapted to the setting of continuous exposures via the
use of conditional densities [16, 20].
Originally, the GPS for continuous exposures was estimated using Gaussian densities, with adjustment for confound-
ing accomplished through either covariate regression [16] or stratification [20]. Several recent methods have aimed
at increasing flexibility for estimating the GPS by using gradient boosting [54], kernel smoothing [9, 24], or ensem-
ble algorithms [27]. Other methods focus on the use of weights [37], including incorporating covariate balancing
properties in estimation using a penalized likelihood approach [10] or constrained optimization on the entropy of the
weights [45, 49]. All of these methods have maintained the assumption that the exposure is univariate, i.e., a single
continuous treatment variable. Methods to accommodate multiple simultaneous treatment exposures have been only
briefly mentioned in the literature [20].
There are many situations in which evaluating the combined effect of multiple simultaneous exposures is critical to
answering scientific questions. In medicine, combination therapies, which involve the patient taking several medi-
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cations simultaneously, have been shown to be effective for treating Crohn’s disease [6], cancer [22], hypertension
[13], and HIV [34]. Typical methods for estimation of the dose response surface for combination treatments requires
careful design with repeated randomized experiments in order to estimate the optimal combination of treatment doses
[25]. When such experimentation is not feasible, researchers may wish to use available data from observational or
non-randomized studies to estimate the joint effects. For example, there is currently interest in studying potential
combination therapies for COVID-19 using available data from non-randomized studies. However, determining a
potentially beneficial dose of several medications may be complicated due to confounding by patient demographic
characteristics, comorbities or other factors [11, 12, 43, 44].
In this article we develop methods to estimate the causal effects of multiple continuous exposures occurring simulta-
neously, using data from a non-randomized study. We develop a general framework for estimating the causal effects
of a multivariate exposure of arbitrary dimension, but focus on bivariate exposures in our simulations and motivating
example. The primary objective is unbiased estimation of the dose-response surface of the average outcome given a
particular combination of exposure values. We propose methods for estimating weights using a multivariate general-
ized propensity score, which we call mvGPS, and use weighted regression to estimate the dose-response surface. Our
methods rely on the assumption that the exposure variables have a multivariate normal distribution.
In Section 2, we introduce our motivating example, which involves assessing the joint effect of two types of inter-
vention strategies for reducing childhood obesity rates in Los Angeles County. In Section 3, we propose a method of
causal inference with multiple simultaneous continuous exposures using the multivariate generalized propensity score.
Section 4 presents a simulation study designed to highlight strengths and limitations of the methodology. Section 5
applies the proposed methods to our motivating example. A discussion in Section 6 concludes the paper.
2 Motivation
Obesity rates among low-income preschool-aged children in Los Angeles County were consistently higher than the
national average in 2003-2009, with about 20% of such children classified as obese (BMI ≥ 30 kg/m2) [35]. In
response, several organizations, including Los Angeles County Department of Public Health, First 5 LA, Nemours,
and the Special Supplemental Nutrition Program for Women, Infants and Children (WIC), implemented programs
and policies aimed at reducing childhood obesity in the county. The interventions used a wide variety of different
approaches and reflected a large investment of resources.
The Early Childhood Obesity Systems Science (ECOSyS) study, funded by National Institute of Health R01
HD072296, sought to evaluate the impact of these programs on childhood obesity prevalence. To this end, ECOSyS
collected information on the nature, timing, location and reach of programs implemented in the county in 2003-2016.
The research team also developed a method of calculating a “community intervention dose index that aggregates ex-
posure to childhood obesity interventions over multiple different programs [52]. The community intervention dose
index is calculated using a multistep procedure. Each program is coded to location and year of implementation, extent
of reach into the target population, and which of nine different intervention strategies it used. The nine strategies
are listed in Table 1. The strategies are categorized as “micro strategies, which target specific individuals, or “macro
strategies, which target a population at large. By aggregating over the strategies implemented in a particular location
during a particular year, strategy-specific as well as total micro and macro intervention dose indices can be calculated.
For this paper, we focus on intervention exposures stemming from WIC programs. WIC serves low-income families
and has seven agencies within Los Angeles County with approximately 90 clinics. While WIC offers many regular
services, primarily food assistance and nutrition education that are uniform from clinic to clinic, WIC agencies can
also receive additional funding to implement intervention programs. These programs are implemented non-randomly
at clinics due to differences in community needs and other considerations. Our motivating example focuses on WIC
intervention programs implemented in 2010-2016, given that a major change in the WIC food package occurred in
2009 that may have altered family behaviors and neighborhood food environments [15, 47].
A total of 32 WIC intervention programs implemented in Los Angeles County from 2010-2016 were cataloged by
the ECOSyS research team. Information about each program was obtained, including how it was implemented, the
estimated reach in terms of client participation, which clinics participated, and how long the program was active. These
exposures were mapped to census tracts where WIC participating children live by identifying the implementing WIC
clinics and then defining a catchment area around the clinic intended to capture the exposed population. Catchment
areas were defined for each clinic using records of client attendance, and varied by strategy type (macro vs. micro).
Children living in census tracts that fell within a catchment area were assumed to be exposed. Exposure values at
census tracts were then aggregated across programs by strategy and by year to obtain a single continuous dose for
each of the nine intervention strategies. Strategy-specific doses were then summed into macro and micro intervention
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doses, which were log transformed due to skewness. More details about the dose construction procedure are provided
in a forthcoming paper.
Figure 1 shows the resultant joint distribution of macro and micro intervention dose for the WIC intervention programs
averaged over our defined intervention period, 2010-2016. Each point in the figure represents a census tract. WIC-
participating children residing in a particular census tract were presumed to receive the calculated doses.
The outcome of interest was change in census tract-level childhood obesity prevalence. Childhood obesity prevalence
was measured using administrative records from children ages 2-5 years who participated in WIC in Los Angeles
County during 2007-2016, compiled by the WIC Data Mining Project, see https://lawicdata.org for more de-
tails. From these records, obesity prevalence by census tract and year was constructed for census tracts with at least 30
WIC-enrolled children. Census tracts used in the analysis were restricted to 8 regions within Los Angeles County that
were targeted as part of the ECOSyS data collection effort. This resulted in a total of n = 1079 census tracts which
serve as the units of analysis. The outcome of interest, Y , was the difference in average obesity prevalence between
post, 2012-2016, and pre, 2007-2009, intervention, i.e., Y = p¯post − p¯pre. The post intervention period was taken to
start in 2012 rather than 2010 to account for potential lag in treatment effects.
We aimed to estimate the dose-response surface of Y, change in childhood obesity prevalence, associated with com-
binations of macro and micro intervention exposure doses, after removing bias due to non-random assignment of
programs. Understanding the simultaneous effect of macro and micro intervention strategy exposures is important to
help policy makers make decisions about the allocation of scarce resources to various intervention strategies [40].
3 Methods
3.1 Notation
Our approach to developing the multivariate generalized propensity score follows the Neyman-Rubin causal model
and uses the potential outcome notation introduced by Neyman [30] and made popular by Rubin [41]. Let Yi denote
the outcome of interest for unit i from a population of size n and Di be a vector of length m providing the values
for m continuous exposures for unit i. The confounders relevant to each exposure are allowed to be different. Let
Ci = {Ci1, . . . ,Cim} be a set of size m where each element in the set, Cij , j = 1, . . . ,m, is a pj dimensional vector
of baseline confounders associated with the jth exposure and the outcome. We denote the value of the kth confounder
of the jth exposure for the ith individual as Cijk, with i = 1, . . . , n, j = 1, . . . ,m, and k = 1, . . . , pj . If all exposures
have identical confounders, then Ci1 = · · · = Cim = Ci and p1 = · · · = pm = p. The observed data for the
ith unit is represented as (Yi, Di1, . . . , Dim, Ci11, . . . , Ci1p1 , . . . , Cim1, . . . , Cimpm). Further, we define the potential
outcome Yi(d) as the outcome that the ith subject would have if assigned the exposure vector d = (d1, . . . , dm). We
will use capital D to represent the multivariate random variable representing dose combinations, and lowercase d as a
particular value in the multidimensional space. Estimation focuses on the average dose-response function defined as
µ(d) = E[Y (d)], which is assumed to be well defined for any d ∈ D ⊆ Rm. Note that with a bivariate exposure, i.e.,
m = 2, µ(d) is a dose-response surface in 3-dimensional space.
3.2 Identification Assumptions
We make the following identifying assumptions: weak ignorability, positivity, and stable-unit treatment value. Weak
ignorability, also known as selection on observables or unconfoundedness, states that exposure is conditionally inde-
pendent of the potential outcomes given the appropriate set of confounders. We write this in the multivariate case
as
Yi(d)⊥⊥Di | Ci1, . . . ,Cim ∀ d ∈ D.
When this assumption holds, we can replace the high-dimensional conditioning set with a scalar value by means of
the conditional density function of exposure [39]. In our case the conditional density is defined as the multivariate
generalized propensity score (mvGPS), which we denote fD|C1,...,Cm . Weak ignorability is often the most difficult
assumption to rationalize as it requires perfect knowledge and collection of all possible confounders of the exposures
and outcome in the set C. We assume that the set C is well defined and that there is no unmeasured confounding.
The second assumption, positivity, claims that all units have the potential to receive a particular level of exposure given
any value of the confounders. In notation, we have
0 < fD|C1,...,Cm(D = d | C1, . . . ,Cm) < 1 ∀ d ∈ D.
This assumption requires that we carefully defineD such that all units have the potential to receive any particular value
in the domain. In the case of a univariate continuous exposure, positivity is often enforced by restricting estimation
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to either the observed range or a trimmed version [7]. For example, using the observed range we would define D =
[d0, d1] where d0 and d1 correspond to the minimum and maximum observed exposure. In the case of a multivariate
exposure, a natural inclination might be to extend this approach to multiple dimensions by setting D = G where G is
defined as
G =
m∏
j=1
[d0j , d1j ] ⊂ Rm,
where d0j and d1j are the minimum and maximum observed exposure, respectively, along dimension j. However,
when exposure variables are correlated, i.e., Cov(Dj , Dj′) 6= 0 for j 6= j′, the region G may include areas with few or
no observations. Instead, we propose defining the estimable region for multivariate exposures as D = H ⊂ G, where
H is defined as the convex hull of the multivariate exposure [5]. Using a convex hull ensures that inference is restricted
to regions where data are observed and avoids extrapolating to sparse data regions in the multidimensional space. For
the case of m = 2, Figure 2 shows the difference between regions G and H when Cov(D1, D2) = 0.5. Additionally,
similar to the univariate case, we can define trimmed versions of G or H. By specifying a value q ∈ [0.5, 1], we
construct Gq using trimmed minimum and maximum values as
Gq =
m∏
j=1
[dq0j , d
q
1j ] ⊂ G,
where dq0j = Q(dj , 1− q), dq1j = Q(dj , q), and Q(·, q) is the sample quantile function. To create the trimmed convex
hull, Hq , we recalculate the convex hull using the subset of observations that falls within the trimmed minimum and
maximum across all exposure dimensions.
The final assumption is the stable-unit treatment value assumption (SUTVA), which states that the potential outcome
of each unit does not depend on the exposure that other units receive and that there exists only one version of each
exposure [42]. This assumption rules out potential interference between units or other errors in defining the potential
outcomes caused by multiple versions of the exposure. Therefore the potential outcomes are well-defined for each unit
and the observed outcome given exposure D = d corresponds to the potential outcome, i.e., Yi(d) = Yi. We discuss
the tenability of this assumption to our data application in the Discussion.
3.3 Multivariate Generalized Propensity Score
Using the identifying assumptions above, there are a variety of different methods to estimate the dose-response func-
tion including covariate adjustment [16] or stratification [20]. We focus on weighted estimation, originally proposed
for binary treatments with marginal structural models [38] and motivated by weights used in survey sampling [17].
We aim to construct a set of weights, w, that when applied to the observed data return a consistent estimate for the
average dose-response function, i.e.,
E[wY | D] = E[Y (d)]. (1)
In the case of univariate continuous exposure, weights are constructed by either estimating the generalized propensity
score [10, 16, 20, 24, 54] or by direct optimization using an entropy loss function [45, 49]. We choose to extend the
generalized propensity score by using an appropriately defined multivariate conditional distribution, which we refer
to as the multivariate generalized propensity score (mvGPS). The weights are thus constructed as the ratio of the
multivariate marginal density to the conditional density
w =
f(D)
f(D|C1, . . . ,Cm) , (2)
where the numerator is the marginal density of the multivariate exposure and the denominator is the mvGPS. These
weights are referred to in the literature as stabilized inverse probability of treatment weights (IPTW) [38]. To motivate
the intuition behind constructing weights in this manner, we can note that w = 1 when the probability of exposure
is independent of the confounding set C, i.e., f(D | C1, . . . ,Cm) = f(D), which would hold in the case of a
randomized experiment. For tractability, we propose using multivariate normal models for both densities, i.e.,
D ∼ Nm(µ,Σ) D | C1, . . . ,Cm ∼ Nm
( β
T
1 C1
...
βTmCm
 ,Ω),
4
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where each βTj is a row vector of length pj corresponding to the effect of the set of confounders Cj on Dj . By
factorizing both the numerator and denominator in Equation 2, we can compute w using full conditionals, i.e.,
w =
f(Dm | Dm−1, . . . , D1) · · · f(D1)
f(Dm | C1, . . . ,Cm, Dm−1, . . . , D1) · · · f(D1 | C1, . . . ,Cm) ,
w =
f(Dm | Dm−1, . . . , D1) · · · f(D1)
f(Dm | Cm, Dm−1, . . . , D1) · · · f(D1 | C1) ,
(3)
where each conditional expression is univariate normal. The second line is a result of the fact that the jth exposure is
independent of the confounders of other exposures given Cj , i.e.,
Dj ⊥⊥C−j | Cj ∀ j = 1, . . . ,m,
where C−j represents the set of confounders excluding Cj , i.e., C−j = {C1, . . . ,Cm} r Cj . Evaluating only
the conditional densities reduces computational burden by eliminating the need to directly estimate the covariance
matrices, Σ and Ω.
Let θ be the collection of mean and variance parameters from all of the univariate normal densities in Equation 3.
Estimation of the parameters to obtain θˆ proceeds by maximizing the corresponding conditional density via least
squares. The weight for the ith subject, wi, is obtained by evaluating the densities using θˆ with the values of the
observed exposures, Di1, . . . , Dim, and confounders, Ci1, . . . ,Cim.
When the weights are properly specified, the covariance between each exposure Dj and confounder Cjk for j =
1, . . . ,m and k = 1, . . . , pj is zero:
E[w(Dj − µDj )(Cjk − µCjk)] =
∫
D
∫
C1
· · ·
∫
Cm
w(dj − µDj )(cjk − µCjk)f(d, c1, . . . , cm)∂d∂c1, . . . , ∂cm
=
∫
D
∫
C
f(d)
f(d|c1, . . . , cm) (dj − µDj )(cjk − µCjk)f(d, c1, . . . , cm)∂d∂c1, . . . , ∂cm
=
∫
D
∫
C
f(d)f(c1, . . . , cm)
f(d|c1, . . . , cm)f(c1, . . . , cm) (dj − µDj )(cjk − µCjk)f(d, c1, . . . , cm)∂d∂c1, . . . , ∂cm
=
∫
D
∫
C
(dj − µDj )(cjk − µCjk)f(d)f(c1, . . . , cm)∂d∂c1, . . . , ∂cm
=
∫
D
(dj − µDj )f(d)∂d
∫
C
(cjk − µCjk)f(c1, . . . , cm)∂c1, . . . , ∂cm
= 0.
(4)
This balancing property of the weights serves as an important diagnostic when using the mvGPS as part of a causal
analysis [2]. Weights that do not reduce the exposure-confounder correlation suggest that the distributional assump-
tions are invalid, the propensity equations are misspecified, or that there are insufficient data as the balance is achieved
asymptotically.
Further, it follows that these weights are already normalized, i.e, E[w] = 1, and they maintain the marginal moments
of D and Cj , meaning E[wDj ] = E[Dj ] and E[wCj ] = E[Cj ] for j = 1, . . . ,m, where the expectations are taken
with respect to the joint density f(D,C1, . . . ,Cm).
It remains to show that the weights as constructed satisfy Equation 1. To do this we follow the logic proposed by
Robins on using IPTW to correct for confounding [37]. We first note that the joint density of the potential outcome
can be factorized as
f(Y (d),D,C1, . . . ,Cm) = f(D | Y (d),C1, . . . ,Cm)f(C1, . . . ,Cm | Y (d))f(Y (d))
= f(D | C1, . . . ,Cm)f(C1, . . . ,Cm | Y (d))f(Y (d)),
where the second line follows from the assumption of weak ignorability. We can then let f(D) be a density for our
multivariate exposure and construct a new joint density f∗ where we replace f(D | C1, . . . ,Cm) with f(D) as would
be the case if the exposures were independent of the confounders. This new density is written as
f∗(Y (d),D,C1, . . . ,Cm) = f(D)f(C1, . . . ,Cm | Y (d))f(Y (d)),
where the marginal mean of the potential outcomes is equivalent under either joint density f or f∗, i.e.,
E∗[Y (d)] = E[Y (d)]. Using this new density we can write our dose response as
E∗[Y (d)] = E∗[Y (d) | D = d] = E∗[Y (D) | D = d] = E∗[Y | D = d],
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using the SUTVA assumption. The resulting expression, E∗[Y | D = d], is equivalent to the mean expression in a
linear regression of the observed exposures on outcome. Finally, we have
E∗[Y | D = d] =
∫
Y
∫
D
∫
C
yf∗(y,d, c1, . . . , cm)∂y∂d∂c1, . . . , ∂cm
=
∫
Y
∫
D
∫
C
y
f∗(y,d, c1, . . . , cm)
f(y,d, c1, . . . , cm)
f(y,d, c1, . . . , cm)∂y∂d∂c1, . . . , ∂cm
=
∫
Y
∫
D
∫
C
y
f(d)
f(d | c1, . . . , cm)f(y,d, c1, . . . , cm)∂y∂d∂c1, . . . , ∂cm
=
∫
Y
∫
D
∫
C
wyf(y,d, c1, . . . , cm)∂y∂d∂c1, . . . , ∂cm
= E[wY | D = d],
(5)
which gives us the result from Equation 1 that our weighted regression does indeed provide a consistent estimate of
the dose-response function.
4 Simulation
4.1 Design
We conducted a simulation study to demonstrate the performance of the mvGPS method under different scenarios of
confounding and compare it to three commonly used univariate methods. The univariate methods were entropy bal-
ancing [45], the covariate balanced generalized propensity score (CBGPS) [10], and the generalized linear propensity
score (PS). The entropy balancing method uses non-parametric constrained optimization with an entropy loss function
to solve for weights without specifying a propensity score model. CBGPS attempts to achieve propensity specification
and covariate balance simultaneously by introducing a penalty term into the likelihood. The PS method uses univariate
normal densities for the marginal distribution of exposure and the generalized propensity score without balance con-
straints. Although these univariate methods can handle only single exposure variables, we expected that they might
perform adequately when the multiple exposure variables are highly correlated and have the same confounders. How-
ever, when exposure variables have separate sets of confounders and/or are only weakly correlated, we expected that
the mvGPS method would outperform the univariate methods.
In our simulations we focus exclusively on a bivariate exposure, m = 2, similar to that found in our motivating
example. For each simulated data scenario, each univariate method was applied twice, once to each exposure variable,
with each such application yielding a set of weights that were used to assess balance on confounders and estimate the
dose-response function.
The first step of the simulation is to draw the vector of covariates X for each unit. We assume that there are a total of
10 covariates collected prior to exposure and that the covariates follow a normal distribution,
X ∼ N10(0,ΣX),
where the covariance matrix ΣX is compound symmetric with variance 1 and covariance 0.2, to create a set of corre-
lated covariates.
Realizations of the conditional distribution of the bivariate continuous exposure levels, D = (D1, D2)T given X, were
then generated as bivariate normal,
D | X ∼ N2(βX,ΣD|X),
where β =
[
βT1
βT2
]
is a 2 × 10 matrix with row vectors βT1 and βT2 representing the effects of X on D1 and D2,
respectively, and ΣD|X is the 2 × 2 conditional covariance matrix. For all simulations the conditional standard
deviation for each exposure was set to 2, while values of the conditional correlation ρD|X were allowed to vary over
{0, 0.1, 0.3, 0.5, 0.7, 0.9}.
Note that the marginal covariance matrix of the exposures, ΣD, is equal to ΣD = ΣD|X + βΣXβ
T . This means
that the marginal correlation of the two exposure variables, ρD, depends on their conditional correlation ρD|X , the
covariance of X and the degree of overlap of covariates. The degree of overlap is reflected in the number of non-zero
elements that are common between βT1 and β
T
2 . As the degree of overlap increases, the marginal correlation also
increases. Since ΣX is compound symmetric with constant covariance of 0.2, the marginal correlation is guaranteed
to be non-zero even with zero overlap and zero conditional correlation.
6
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Finally, the outcome Y was sampled from a univariate normal distribution conditional on D and X as
Y | D,X ∼ N
(
αT
[
X
D
]
, σ2Y
)
= N(αTXX + α
T
DD, σ
2
Y ),
where αT =
[
αTX α
T
D
]
is a 1× 12 vector of coefficients, which we separate as αTX, a 1× 10 vector representing the
effect of covariates on the outcome, and αTD, a 1× 2 vector corresponding to the treatment effects. In all simulations
the conditional standard deviation of the outcome was equal to 4, i.e., σY = 4.
Three scenarios were constructed to reflect different degrees of overlap of confounding for the two exposures: M1:
No Common Confounding, M2: Partially Common Confounding, and M3: Common Confounding. Directed acyclic
graphs (DAGs) for each scenario are shown in Figure 3.
Tables 2, 3, and 4 display the coefficients in the vectorsβT1 , β
T
2 andα
T for each scenario. In M1, the two exposuresD1
and D2 each have five covariates, with none in common; for each exposure, two of the covariates are true confounders
(i.e., also associated with Y ). The outcome Y is a function of the two exposures as well as the four true confounders,
none of which are shared between D1 and D2. In M2, D1 and D2 again have five covariates each, but they share three
in common. Two of the shared covariates are true confounders, and each exposure has a confounder that is not shared
with the other exposure. The outcome Y is again a function of the two exposures and the four true confounders, two
of which are shared and two of which are not. In M3, D1 and D2 share the same five covariates. Four of these are true
confounders, and Y is a function of the two exposures and four common confounders. In all scenarios, the treatment
effect for each of the exposures was set to 1, i.e., αTD = (1, 1).
The three simulation scenarios were run with a sample size of n = 200 for a total of B = 1000 Monte Carlo
repetitions using R Version 4.0 [36]. For each repetition, weights were estimated using mvGPS and the three univariate
methods with the proper set of confounders specified for each exposure. For example, for Scenario M1, weights were
constructed for D1 using X2 and X4 while D2 depended on X6 and X9 (see Table 2). The three univariate methods,
entropy balancing, CBGPS and PS, were implemented using the WeightIt package in R [14]. The parametric version
of CBGPS was used. The mvGPS method was implemented using the mvGPS package in R. All methods were
compared against an unweighted approach equivalent to applying a weight of 1 to all observations.
Weighted Pearson correlations between the exposures and confounders were used to assess balancing performance
[2, 54]. We examined maximum absolute correlation, which reflects the most imbalanced confounder after weighting
and has been shown to be a key metric to assess balance [8], and the average absolute correlation, which summarizes
how well balance is achieved over all confounders. These correlation values were taken over both sets of exposures.
Effective sample sizes, (Σiwi)2/Σiw2i , were calculated to summarize the relative power of each method [26]. The
weights were then used to estimate the dose-response model. The performance metrics were absolute total bias,
Σj |αDj − αˆDj | for j = 1, 2, and root mean squared error,
√
1
nΣi(y
∗
i − yˆi)2, where i = 1, . . . , 500 samples, y∗, were
drawn from a uniform grid on the convex hull, H, over the observed joint distribution of the two exposures. Each of
the metrics was averaged over the 1000 repetitions.
All methods reduce the effective sample size when weights are applied to the sample. Of particular concern for
practitioners are extreme weights. When sample sizes are small or moderate, extreme weights can have an outsized
influence. They may also result in limited power to detect treatment effects and erratic estimation [23]. One remedy
is to trim extreme weights [18, 28]. As all simulations were run with moderate sample sizes, i.e., n = 200, we wanted
to test performance when weight trimming was applied as might be done in practice by analysts when faced with
extreme weights. Our simulation analyses were thus repeated using trimmed weights for each method, wq , where
q ∈ {0.99, 0.95}. Weights were trimmed at both the upper and lower bounds of the respective sample percentile such
that values above or below the thresholds were replaced with the threshold value.
4.2 Simulation Results
Figure 4 plots the absolute maximum correlation between the exposures and confounders for each method along
with the original unweighted correlations for comparison. In general, with no common confounding or partially
common confounding, the mvGPS method substantially outperformed each univariate method. However, for common
founding, mvGPS performs best only when the marginal correlation is low. The performance of univariate methods
tended to cluster differently based on the degree of confounding overlap. In models with low overlap, performance
was clustered based on exposure, D1 or D2, but as the degree of overlap increased, performance became clustered by
type of estimation, Entropy, CBGPS, or PS. Applying trimmed weights, we see a slight improvement for q = 0.99
while q = 0.95 has little to no effect.
7
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Figure 5 shows the average absolute exposure-covariate correlation along with a reference line at 0.1, a benchmark
suggesting sufficient covariate balance [54]. For all simulation models, the mvGPS is consistently near the 0.1 thresh-
old. For the univariate methods, we see trends in performance similar to those observed for the maximum correlation,
but differences between methods are smaller. Entropy methods consistently had the lowest average correlation, es-
pecially with high overlap or high marginal correlation. Trimming the weights tended to eliminate the effect of the
marginal correlation on the mvGPS, resulting in flatter lines for q = 0.99 and q = 0.95, particularly for models with
at least some common confounding.
Figure 6 displays trends in effective sample size for each method across the various simulation scenarios, with a
reference line at 100, which is often a minimum desirable quantity for inference in the dose-response model [49].
The mvGPS method tends to have lower effective sample sizes compared to the univariate methods. Importantly,
using untrimmed weights, the mvGPS method has effective sample sizes less than 100 in the presence of partial or
common confounding, indicating particularly low power. Trimming the weights increases the effective sample size
for all methods and the difference between methods decreases as q increases.
Figure 7 shows the results of each method with respect to total absolute bias for the treatment effects estimated from
weighted regression. Generally, the mvGPS method has the lowest total bias, with the exception of high correlation in
the model with partially common confounding or no common confounding. Of particular note, although the effective
sample size and balancing diagnostics were lower for mvGPS in the common confounding model, it significantly
outperforms all univariate methods with respect to bias even with high marginal correlation. We also observe that
certain univariate methods have greater bias than the unweighted estimates, such as those that estimate weights using
D2 for the common confounding model. Trimming the weights tended to reduce bias for mvGPS when there was high
correlation of the exposures, particularly under models with either partially overlapping confounding or no common
confounding, while slightly increasing the bias for the common confounding models.
Figure 8 shows the root mean squared error based on 500 points sampled along a grid from the convex hull, Hq ,
of the exposures. The precision of predicted values for the mvGPS is often worse than that for univariate methods.
As ρ increases, the mvGPS method has worse performance, with decreased power from low effective sample sizes.
Trimming the weights helps reduce this trend and reduces the root mean squared error across all methods.
In summary, using a multivariate method for weight estimation is critical to achieve balance as univariate methods in
general do not effectively balance on the confounders for both exposures. The multivariate method protects against
any single confounder being strongly imbalanced across either exposure at the expense of slightly lower average
balance, while the univariate methods have potentially large imbalance on the unused exposure dimension. The notable
exception is when there is high overlap in terms of confounders. In this case univariate methods can sufficiently balance
confounders, particularly when the marginal correlation of exposures is high. However, despite achieving balance in
these scenarios, the univariate methods still resulted in high total bias of the treatment effect estimates. Although
mvGPS weights were advantageous with respect to balance and bias, they tend to produce smaller effective sample
sizes, resulting in lower power and higher root mean squared error. Weight trimming, particularly with q = 0.99,
offers a potential remedy to reduce these effects while also maintaining balance and low bias.
5 Effect of Intervention Strategies on Childhood Obesity Prevalence
The WIC program is designed to provide nutrition education, ’vouchers’ for selected healthy food, and referrals. The
rapid increase in childhood obesity rates in the early 2000s led to interventions to increase physical activity, and
improve access to healthy food especially in communities where affordable fresh produce is not available. In this
motivating example, we estimated the causal effects of interventions that were implemented by individual WIC clinics
in attempts to meet the specific needs of the communities they served. As discussed in Section 2, the intervention
programs were classified as using macro or micro strategies and we calculated two continuous dose measures for
n = 1079 census tracts. The outcome was the difference in average obesity prevalence from post, 2012-2016, to pre,
2007-2009, intervention period, calculated as Y = p¯post− p¯pre at the census tract level. Negative values of Y indicate
that the prevalence of obesity decreased. We hypothesized that areas with more macro and micro strategies would
have the greatest reduction in rates of obesity.
Data on potential census tract-level confounders came from three sources: US Census American Community Sur-
vey (ACS) 5-year estimates [46], WIC administrative data, and the National Establishment Time-Series (NETS) [51].
Variables from the ACS captured community level demographic characteristics such as median household income,
education level, primary language spoken at home, and ethnicity, which have been shown in previous research to be
associated with obesity rates [31, 32]. WIC administrative data were used to calculate average pre-treatment over-
weight and obesity prevalence for each census tract. Overweight and obesity prevalence were considered potential
confounders because agencies may have directed interventions towards clinics in higher prevalence regions. Finally,
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NETS provided information on neighborhood food environments, specifically on the density per square mile of un-
healthy and healthy food outlets [1, 53]. Previous analysis has shown that higher density of healthy outlets was
associated with lower obesity prevalence among low-income preschool-aged children in Los Angeles County [4].
Both macro and micro propensity dose equations included the same set of potential confounders from these three data
sources, but each exposure was assessed separately to determine if higher order polynomial terms for any confounders
were needed. These analyses showed that both macro and micro dose had quadratic relationships with education level
and density of food outlets, while only macro dose had evidence of a quadratic relationship with median household
income.
After defining the appropriate functional form for each exposure and confounder, weights were then estimated using
the mvGPS method and the three univariate methods discussed in Section 4.1. To maintain the assumption of positivity,
data used for estimating the weights were restricted to the trimmed convex hull H0.95 shown in Figure 1, where a
bivariate normal distribution is plausible. The marginal correlation of exposures was moderate, r = 0.28, in this high-
density region. As both exposures had nearly identical sets of potential confounders, the data generating mechanism
was akin to the common confounding scenario described in the simulations. Therefore, to protect against extreme
weights and reduce the variability of the resulting dose-response estimates, weights for each method were trimmed
using q = 0.99.
Table 5 shows the balancing diagnostics, maximum absolute correlation and average absolute correlation, and the
effective sample sizes. The confounders were significantly imbalanced prior to weighting with the average absolute
correlation above 0.2 and the maximum absolute correlation above 0.4. All methods were able to improve balance,
but the mvGPS method had substantially greater reduction in imbalance than the univariate methods. The average
absolute correlation and maximum absolute correlation were reduced to 0.04 and 0.10 respectively after applying
mvGPS weights. The effective sample size for mvGPS was reduced from the original sample of n = 1079 to 604.
However, since the population included over 1000 census tract units, the power was still reasonably high.
Finally, we applied weights from the mvGPS method to estimate the joint effect of macro and micro exposure doses on
change in obesity prevalence using weighted least squares regression and compare these to unweighted estimates. Only
exposures within the trimmed convex hull,H0.95, were used to estimate treatment effects and predict the dose-response
surface. The dose-response model for both methods included linear terms for each exposure and an interaction between
the two exposures.
Figure 9 shows the weighted and unweighted dose-response surfaces along with a reference plane of no change in
obesity prevalence. Both the weighted and unweighted surfaces suggest reductions in obesity prevalence from our
pre-intervention period, 2007-2009, to the post-intervention period, 2012-2016, for all dose combinations. This is
consistent with studies showing a decrease in obesity risk among WIC-participating children in Los Angeles County
associated with the 2009 change in the WIC food packages [3, 33]. The unweighted dose-response surface is a
monotonic plane; increases in micro dose and in macro dose are each associated with greater reduction in obesity
prevalence, the associations are additive, and the greatest reduction in prevalence corresponds to the highest levels of
macro and micro doses. The mvGPS dose-response surface is more complex and shows an interaction effect. At low
levels of macro dose, increases in micro dose are associated with a steep reduction in obesity prevalence. However,
as macro dose increases, high micro dose becomes gradually less effective. In the quadrant where both macro and
micro dose are high, higher micro doses appear to be less beneficial rather than more beneficial. There are several
possible explanations for this result. There could be important confounders that were not accounted for in the analysis.
There could also have been measurement error in estimating exposures. We noted that the data set included several
observations with high macro and high micro doses that were assigned high weights and had either no decrease or a
slight increase in child obesity prevalence. Further investigation of these census tracts may yield more information
and guide model refinements.
6 Discussion
In this manuscript, we introduced methodology for generating a multivariate generalized propensity score, mvGPS,
to be used in estimating the causal effect of multiple simultaneous continuous exposures in observational or non-
randomized studies. We have developed the R package mvGPS available at https://github.com/williazo/mvGPS
to implement the methods.
Through simulations we have shown that, when estimating the causal effects of two simultaneous exposures, mvGPS
weights are effective at reducing both the maximum and average absolute correlation between exposures and con-
founders. Further, the weights can minimize bias in estimating the dose-response function in realistic data generating
settings with moderate sample sizes. The simulations identified two key factors that affect performance. When the
exposures have highly overlapping sets of confounders or large marginal correlation, the mvGPS method may generate
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extreme weights, resulting in smaller effective sample sizes and higher average root mean squared error. Trimming
the weights improves performance in these situations. We suggest that in settings with a high degree of overlap in the
confounders or moderate to large marginal exposure correlation, weights should be trimmed at q = 0.99.
While our method could in principle be extended to an arbitrary number of continuous exposures, we have confined
attention in our simulations and application to the setting of two exposures. Assessing the joint effect of two inter-
ventions is a common scientific question, and we expect that there are many practical applications of the methods.
The resulting dose-response surface for bivariate exposures can be easily visualized and interpreted, which is key in
practice. Further work is needed to explore performance for settings with more than two exposures. In particular, pos-
itivity and achieving adequate balance may be increasingly difficult as dimensions of exposure increase. For higher
order exposures, dimension reduction techniques such as principal component analysis or manifold learning might be
applied to transform the problem to a lower order continuous exposure space.
We applied the mvGPS method to evaluate the joint effectiveness of macro and micro intervention strategies used in
childhood obesity programs on change in obesity prevalence among low-income preschool aged children. Due to non-
random selection of participating clinics, there was significant imbalance on potential confounders as evidenced by
large absolute maximum and average correlations prior to weighting. The mvGPS method achieved superior balance
compared to univariate alternatives, reducing the maximum absolute correlation to the benchmark of 0.1 and the
average absolute correlation to nearly zero. Estimates of the dose-response surface using weights from the mvGPS
method differed substantially from the results of the unweighted surface. The results showed that the most effective
intervention combination was higher levels of micro strategies and lower levels of macro strategies. However, our
results should be interpreted with caution. As with other causal inference methods, all confounders must be adequately
captured and modeled to produce unbiased estimates. Thus our estimated treatment effects may be biased due to
unknown confounders. In particular, communities that received higher levels of macro and micro doses may have been
inherently more difficult to change due to a complex interplay of community and personal factors not captured by our
set of potential confounders. In addition, we have assumed that the potential outcomes of the change in obesity given
macro and micro exposures are well-defined via SUTVA as discussed in Section 3.2. Specifically, SUTVA stipulates
that multiple versions of the exposures do not exist. In our application, however, there are potentially different sets
of interventions that can yield the same macro and micro exposure scores. In the presence of multiple versions of
the exposures, the resulting potential outcomes may be unidentifiable. Further, we had to estimate exposure to the
interventions at the census tract level using various assumptions, which may have resulted in measurement error. Thus
our application, while demonstrating the methods, has important limitations.
Our approach assumes that the exposures have a multivariate normal distribution. The multivariate normal distribution
is particularly attractive for working in higher dimensions. In our case, it allows for the full conditionals used to gener-
ate weights in Equation 3 to be tractable univariate normal densities. Further, the asymptotics of the estimates are well
behaved due to the central limit theorem. We note that it is common practice when using the generalized propensity
score for continuous treatments in the univariate case to assume normality [10, 16, 20, 37, 54]. However, this reliance
on multivariate normality is an important limitation of the methodology, particularly in assessing its validity [29].
Possible extensions include replacing the multivariate normal distribution with non-parametric or semi-parametric al-
ternatives as has been done recently with univariate methods [24, 45, 49]. Other possible extensions include allowing
for time-varying outcomes and exposures such has been recently proposed for CBGPS [19]. Additionally, SUTVA
might be relaxed to test for potential geographic interference [48, 50].
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Tables and Figures
Table 1: Intervention Program Strategies
# Name Group n (%)
1 Government Policies Macro 1 (3%)
2 Institutional Polices Macro 4 (12%)
3 Infrastructure Investments Macro 3 (9%)
4 Business Practices Macro 4 (12%)
5 Group Education Micro 21 (66%)
6 Counseling Micro 14 (44%)
7 Health Communication Micro 17 (53%)
8 Home Visitation Micro 8 (25%)
9 Screening and Referral Micro 14 (44%)
Each intervention program was classified based on the strategies that were implemented. Programs could use multiple
strategies, e.g., Group Education and Counseling. Strategies are categorized as either micro and macro based on
whether they directly targeted individuals or the population at large. The final column represents how many of the 32
programs used that particular strategy.
Table 2: Coefficients for Simulation Scenario M1: No Common Confounding
Param. X1 X2 X3 X4 X5 X6 X7 X8 X9 X10 D1 D2
D1 β
T
1 1 0.5 0.25 0.1 0.75 0 0 0 0 0 - -
D2 β
T
2 0 0 0 0 0 1 0.5 0.25 0.1 0.75 - -
Y αT 0 0.5 0 1 0 0.2 0 0 1 0 1 1
All values of the covariates enter in each equation linearly with the respective coefficients shown in the table. In this
scenario, covariates X1 −X5 are associated with exposure D1; however, only X2 and X4 are true confounders also
associated with Y . Similarly, covariates X6 − X10 are associated with exposure D2; however, only X6 and X9 are
true confounders also associated with Y . There are no common confounders in this model. Each exposure has a true
treatment effect coefficient of 1.
Table 3: Coefficients for Simulation Scenario M2: Partially Common Confounding
Param. X1 X2 X3 X4 X5 X6 X7 X8 X9 X10 D1 D2
D1 β
T
1 0 0 1 0.5 0.25 0.1 0.75 0 0 0 - -
D2 β
T
2 0 0 0 0 1 0.5 0.25 0.1 0.75 0 - -
Y αT 0 0 0.5 0 0 1 0.2 0 1 0 1 1
All values of the covariates enter in each equation linearly with the respective coefficients shown in the table. In this
scenario, covariates X3 −X7 are associated with exposure D1; however, only X3, X6, and X7 are true confounders
also associated with Y . Similarly, covariates X5 − X9 are associated with exposure D2; however, only X6 X7, and
X9 are true confounders also associated with Y . Common confounders of exposure D1 and D2 are X6 and X7.
Confounder of exposure D1 only is X3, and X9 is a confounder of D2 only. Each exposure has a true treatment effect
coefficient of 1.
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Table 4: Coefficients for Simulation Scenario M3: Common Confounding
Param. X1 X2 X3 X4 X5 X6 X7 X8 X9 X10 D1 D2
D1 β
T
1 1 0.5 0.25 0.1 0.75 0 0 0 0 0 - -
D2 β
T
2 0.8 0.8 0.05 0.4 0.55 0 0 0 0 0 - -
Y αT 0.5 0 1 0.2 1 0 0 0 0 0 1 1
All values of the covariates enter in each equation linearly with the respective coefficients shown in the table. In this
scenario, covariates X1 − X5 are associated with exposure D1 and D2; however, only X1, X3, X4 and X5 are true
confounders also associated with Y . Common confounders of exposure D1 and D2 are X1, X3, X4, and X5. There
are no confounders of D1 or D2 only in this model. Each exposure has a true treatment effect coefficient of 1.
Table 5: Covariate Balance
Max Abs. Corr. Avg. Abs. Corr. ESS Method
0.10 0.04 604 mvGPS
0.19 0.09 578 CBGPS (Macro)
0.21 0.08 672 PS (Macro)
0.21 0.08 540 Entropy (Macro)
0.35 0.11 768 Entropy (Micro)
0.36 0.13 807 PS (Micro)
0.41 0.15 685 CBGPS (Micro)
0.41 0.20 1079 Unweighted
Assessing balance and effective sample size (ESS) using various weighted methods for the motivating example. Data
used for estimating weights were restricted to H0.95. The univariate methods were applied separately to the two
exposure metrics, macro or micro dose. The correlations are taken over both exposure metrics. The unweighted
method represents the original values before applying weights. The weights for each method are trimmed using
q = 0.99.
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Figure 1: Joint Distribution of Macro and Micro Intervention Doses
Observed values of log macro and micro exposure doses averaged over the study intervention period 2010-2016.
Trimmed convex hull region with q = 0.95, i.e.,H0.95, is shown in red
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Figure 2: Defining Estimable Region with Bivariate Exposure
Sample of n = 500 units drawn from population where D1 ∼ N(0, 1), D2 ∼ N(0, 1), Cov(D1, D2) = 0.5. Region
defined by dark blue box corresponds to G while region defined in dark red represents H. Trimmed regions are also
shown for q = 0.95 with the light blue box corresponds to G0.95 while the region defined in light red representsH0.95
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Figure 3: Simulation Scenarios
Directed acyclic graphs for each of the three data generating simulation scenarios. D1 andD2 are continuous exposure
measures and Y is the outcome of interest. C1 and C2 represent confounder sets that are specific to exposures D1 and
D2, while C12 represents a confounder set common to both exposures.
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Figure 4: Assessing Covariate Balance: Maximum Absolute Exposure-Covariate Correlation
Rows correspond to the three simulation scenarios, M1, M2 and M3, and each column corresponds to quantiles used
for weight trimming. The y-axis is the average maximum absolute exposure-covariate correlation for n = 200 from
B = 1000 repetitions. This maximum is taken across both exposure values, D1 and D2. The x-axis, ρ, is the marginal
correlation of the exposures. For univariate methods, weights were generated twice, once for each exposure variable.
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Figure 5: Assessing Covariate Balance: Average Absolute Exposure-Covariate Correlation
Rows correspond to the three simulation scenarios, M1, M2 and M3, and each column corresponds to quantiles used
for weight trimming. The y-axis is the average absolute exposure-covariate correlation for n = 200 from B = 1000
repetitions. This average is taken across both exposure values, D1 and D2. The x-axis, ρ, is the marginal correlation
of the exposures. For univariate methods, weights were generated twice, once for each exposure variable. The red line
corresponds to an average value of 0.1, which is often used as a benchmark for sufficient balance.
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Figure 6: Effective Sample Size
Rows correspond to the three simulation scenarios, M1, M2 and M3, and each column corresponds to quantiles used
for weight trimming. The y-axis is the average effective sample size, (Σiwi)2/Σiw2i , for n = 200 from B = 1000
repetitions. The x-axis, ρ, is the marginal correlation of the exposures. The red line corresponds to an effective sample
size of 100 which is often a minimum desirable quantity for hypothesis testing and inference of the dose-response
model.
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Figure 7: Outcome Modeling Performance Metric: Average Total Absolute Bias
Rows correspond to the three simulation scenarios, M1, M2 and M3, and each column corresponds to quantiles used
for weight trimming. The y-axis is the average total absolute bias, Σj |αDj − αˆDj |, for n = 200 from B = 1000
repetitions. The x-axis, ρ, is the marginal correlation of the exposures. For univariate methods, weights were generated
twice, once for each exposure variable.
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Figure 8: Outcome Modeling Performance Metric: Average RMSE
Rows correspond to the three simulation scenarios, M1, M2 and M3, and each column corresponds to quantiles used
for weight trimming. The y-axis is the average root mean squared error (RMSE) for 500 points sampled on a convex
hull Hq grid for n = 200 from B = 1000 repetitions. The x-axis, ρ, is the marginal correlation of the exposures. For
univariate methods, weights were generated twice, once for each exposure variable.
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Figure 9: Estimated Dose-Response Surface of Change in Obesity Prevalence as a Function of Macro and Micro
Intervention Dose
Estimated dose-response surface of change in obesity prevalence as a function of log macro and micro dose, obtained
using mvGPS weights and unweighted. The surface is restricted to the convex hull of observed bivariate exposure,
H0.95, shown in Figure 1 and points are sampled evenly along this grid. A reference plane of no change is included.
For a 3D interactive version of the dose-response surface that includes lower and upper bound 95% confidence interval
surfaces for the mvGPS method, visit https://williazo.github.io/resources/.
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